Mikal C. Watts Named Co-Lead Counsel of Pradaxa Multi-District Litigation

On September 28, 2012, Chief Judge Herndon of the Southern District of Illinois appointed the Plaintiffs Steering Committee for In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigations, MDL No. 2385. San Antonio, Texas (PRWEB) October 04, 2012 As part of his leadership appointments, Chief Judge Herndon selected Mikal C. Watts to serve as Co-Lead Counsel for the Pradaxa litigation nationally. Pradaxa was approved in October 2010 by the FDA for the prevention of stroke in patients with non-valvular atrial fibrillation, and was the first alternative to warfarin approved in nearly
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations